Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
Mechanics in Neuronal Development and Repair.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
Brain MRI abnormalities in Brazilian patients with neuromyelitis optica.
Multiple sclerosis: Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Atorvastatin: Multiple Sclerosis.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature.
Care of patients with multiple sclerosis.
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
Anorexia heralding the onset of neuromyelitis optica.
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.
Current status of myelin replacement therapies in multiple sclerosis.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Pages
« first
‹ previous
…
267
268
269
270
271
272
273
274
275
…
next ›
last »